Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature
Rudolf Likar, Markus Koestenberger, Martin Stultschnig, et al.
Anticancer Research (2019) Vol. 39, Iss. 10, pp. 5797-5801
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
Emily S. Seltzer, Andrea Watters, Danny MacKenzie, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3203-3203
Open Access | Times Cited: 196
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
Donald I. Abrams
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 39
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
Tereza Buchtová, David Lukac, Zdeněk Škrott, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2885-2885
Open Access | Times Cited: 23
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
Farjana Afrin, Mengna Chi, Andrew L. Eamens, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1033-1033
Open Access | Times Cited: 55
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
Gerhard Nahler
Pharmaceutical Medicine (2022) Vol. 36, Iss. 2, pp. 99-129
Open Access | Times Cited: 33
Cannabidiol Combination Enhances Photodynamic Therapy Effects on MCF-7 Breast Cancer Cells
Dimakatso Mokoena, Blassan P. George, Heidi Abrahamse
Cells (2024) Vol. 13, Iss. 2, pp. 187-187
Open Access | Times Cited: 7
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Vamsi Reddy, Dayton Grogan, Meenakshi Ahluwalia, et al.
The EPMA Journal (2020) Vol. 11, Iss. 2, pp. 217-250
Open Access | Times Cited: 34
Cannabis sativa subsp. sativa’s pharmacological properties and health effects: A scoping review of current evidence
Xin Yi Lim, Terence Yew Chin Tan, Siti Hajar Muhamad Rosli, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245471-e0245471
Open Access | Times Cited: 30
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports
Jordan Guggisberg, Megan L. Schumacher, Grace Gilmore, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 1, pp. 24-33
Open Access | Times Cited: 29
Cannabinoids in glioblastoma multiforme—hype or hope?
Gary J. Doherty, Bruno de Paula
British Journal of Cancer (2021) Vol. 124, Iss. 8, pp. 1341-1343
Open Access | Times Cited: 27
Ion Channels in Gliomas—From Molecular Basis to Treatment
Abdallah F. Elias, Bernice Lin, Beverly J. Piggott
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2530-2530
Open Access | Times Cited: 12
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment
Hesam Khodadadi, Évila Lopes Salles, Ahmet Alptekin, et al.
Cannabis and Cannabinoid Research (2021) Vol. 8, Iss. 5, pp. 824-834
Closed Access | Times Cited: 22
Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models
Liliana Soroceanu, Eric A. Singer, Pratiksha Dighe, et al.
Neuro-Oncology Advances (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 15
Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats
Danielle Hen-Shoval, Lital Moshe, Talia Indig-Naimer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3828-3828
Open Access | Times Cited: 7
Cannabidiol Μay Prolong Survival in Patients With Glioblastoma Multiforme
Rudolf Likar, Markus Koestenberger, Martin Stutschnig, et al.
Cancer Diagnosis & Prognosis (2021) Vol. 1, Iss. 2, pp. 77-82
Open Access | Times Cited: 14
Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives
Florence Lefranc
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 12
miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth
Nan Yang, Liyun Guo, Yingwei Zhen, et al.
Cell Cycle (2021) Vol. 20, Iss. 19, pp. 1967-1977
Open Access | Times Cited: 12
Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors
Michelle Goulette, Nicolas J. Schlienz, Amy A. Case, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Cannabis and the Cancer Patient
Ilana M. Braun, Donald I. Abrams, Stacey E Blansky, et al.
JNCI Monographs (2021) Vol. 2021, Iss. 58, pp. 68-77
Open Access | Times Cited: 8
Cannabidiol bei Tumorerkrankungen
Rudolf Likar, Markus Köstenberger, Gerhard Nahler
Der Schmerz (2020) Vol. 34, Iss. 2, pp. 117-122
Closed Access | Times Cited: 6
Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma
Claudia A. Dumitru, Eileen Brouwer, Tamina Stelzer, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2624-2624
Open Access | Times Cited: 6
Cannabidiol promotes apoptosis of osteosarcoma cells in vitro and in vivo by activating the SP1-CBX2 axis.
Fangxing Xu, Guiyuan Sun, Zhibin Peng, et al.
PubMed (2022) Vol. 14, Iss. 2, pp. 1188-1203
Closed Access | Times Cited: 4
Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles
Dhiraj J. Pangal, Hans Baertsch, Eliza M. Kellman, et al.
World Neurosurgery (2021) Vol. 151, pp. e682-e692
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top